|
US4559157A
(en)
|
1983-04-21 |
1985-12-17 |
Creative Products Resource Associates, Ltd. |
Cosmetic applicator useful for skin moisturizing
|
|
LU84979A1
(fr)
|
1983-08-30 |
1985-04-24 |
Oreal |
Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
|
|
DE3441788A1
(de)
|
1984-11-15 |
1986-05-15 |
Bayer Ag, 5090 Leverkusen |
Alkyl-1-cyclopropyl-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
|
|
US4820508A
(en)
|
1987-06-23 |
1989-04-11 |
Neutrogena Corporation |
Skin protective composition
|
|
US4992478A
(en)
|
1988-04-04 |
1991-02-12 |
Warner-Lambert Company |
Antiinflammatory skin moisturizing composition and method of preparing same
|
|
US4938949A
(en)
|
1988-09-12 |
1990-07-03 |
University Of New York |
Treatment of damaged bone marrow and dosage units therefor
|
|
US7655699B1
(en)
|
1992-04-22 |
2010-02-02 |
Eisai Inc. |
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
|
|
EP0983992B1
(en)
|
1992-04-22 |
2005-10-26 |
Ligand Pharmaceuticals Incorporated |
Compounds having selectivity for retinoid x receptors
|
|
US5780676A
(en)
|
1992-04-22 |
1998-07-14 |
Ligand Pharmaceuticals Incorporated |
Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
|
|
US5962731A
(en)
|
1992-04-22 |
1999-10-05 |
Ligand Pharmaceuticals Incorporated |
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
|
|
US6137002A
(en)
|
1993-07-22 |
2000-10-24 |
Eli Lilly And Company |
Glycoprotein IIb/IIIa antagonists
|
|
WO1997012853A1
(en)
*
|
1995-10-06 |
1997-04-10 |
Ligand Pharmaceuticals Incorporated |
Dimer-selective rxr modulators and methods for their use
|
|
FR2746101B1
(fr)
*
|
1996-03-14 |
1998-04-30 |
|
Composes bicycliques-aromatiques
|
|
EP0973390A4
(en)
*
|
1997-04-11 |
2003-03-19 |
Sidney Kimmel Cancer Ct |
RETINOID-RELATED MOLECULES FOR ENHANCING ENDOTHELIN 1 OVERPRODUCTION IN CONDITION
|
|
FR2776657B1
(fr)
*
|
1998-03-31 |
2000-05-26 |
Cird Galderma |
Composes bicycliques-aromatiques et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetologie
|
|
ID26632A
(id)
*
|
1998-05-06 |
2001-01-25 |
Galderma Res & Dev |
Pengujian terhadap identifikasi senyawa yang mengangkat produksi melamin dan retinoid seperti senyawa yang didentifikasi tersebut
|
|
US6869959B1
(en)
|
1999-04-28 |
2005-03-22 |
Institute Of Medicinal Molecular Design Inc. |
Heterocyclic carboxylic acid derivatives
|
|
US6291677B1
(en)
|
2000-08-29 |
2001-09-18 |
Allergan Sales, Inc. |
Compounds having activity as inhibitors of cytochrome P450RAI
|
|
US6313107B1
(en)
|
2000-08-29 |
2001-11-06 |
Allergan Sales, Inc. |
Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
|
|
ES2256288T3
(es)
|
2000-08-29 |
2006-07-16 |
Allergan, Inc. |
Compuestos con actividad como inhibidores de citocromo p450rai.
|
|
US6303785B1
(en)
|
2000-08-29 |
2001-10-16 |
Allergan Sales, Inc. |
Compounds having activity as inhibitors of cytochrome P450RAI
|
|
AU2003301226A1
(en)
|
2002-12-20 |
2004-07-22 |
Pharmacia Corp |
Acyclic pyrazole compounds for the inhibition of mitogen activated protein kinase-activated protein kinase-2
|
|
EP1653939A2
(en)
*
|
2003-08-07 |
2006-05-10 |
Allergan, Inc. |
Method for treating cachexia with retinoid ligands
|
|
EP1541549A1
(en)
|
2003-12-12 |
2005-06-15 |
Exonhit Therapeutics S.A. |
Tricyclic hydroxamate and benzaminde derivatives, compositions and methods
|
|
US7226951B2
(en)
|
2003-12-17 |
2007-06-05 |
Allergan, Inc. |
Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
|
|
CA2550010A1
(en)
|
2003-12-17 |
2005-06-30 |
Allergan, Inc. |
Methods for treating retinoid responsive disorders using selective inhibitors of cyp26a and cyp26b
|
|
US20080234229A1
(en)
*
|
2005-08-18 |
2008-09-25 |
Auspex Pharmaceuticals, Inc. |
Novel Therapeutic Agents for the Treatment of Cancer, Metabolic Diseases and Skin Disorders
|
|
WO2008025965A2
(en)
*
|
2006-08-29 |
2008-03-06 |
Reinnervate Limited |
Retinoid compounds and their use
|
|
CN109503446B
(zh)
|
2007-01-15 |
2021-08-20 |
于崇曦 |
维生素a酸类和类维生素a酸化合物的前药
|
|
US9056085B2
(en)
|
2009-02-03 |
2015-06-16 |
Children's Medical Center Corporation |
Methods for enhancing hematopoietic stem/progenitor cell engraftment
|
|
US20120115912A1
(en)
*
|
2009-07-10 |
2012-05-10 |
Landreth Gary E |
Rxr agonist compounds and methods
|
|
CN102892755A
(zh)
*
|
2009-12-23 |
2013-01-23 |
韦恩州立大学 |
治疗性化合物
|
|
AU2011218019B2
(en)
*
|
2010-02-19 |
2016-03-24 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University |
Novel bexarotene analogs
|
|
JP5743129B2
(ja)
|
2010-04-16 |
2015-07-01 |
Dic株式会社 |
重合性化合物を含有する液晶組成物及びそれを使用した液晶表示素子
|
|
WO2013040227A2
(en)
|
2011-09-15 |
2013-03-21 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University |
Therapeutic compounds
|